A Phase I Study of Cabozantinib (XL184) in Patients with Differentiated Thyroid Cancer

le Cabanillas, Maria E., Brose, Marcia S., Holland, Jaymes, Ferguson, Kimberly C., Sherman, Steven I.
Foilsithe 2014

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy

le Cloughesy, Timothy F, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Ping, Jerry, Holland, Jaymes, Weitzman, Ron, Wen, Patrick Y
Foilsithe in Neuro Oncol (2018)

Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapy

le Wen, Patrick Y, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Holland, Jaymes, Ping, Jerry, Weitzman, Ron, Cloughesy, Timothy F
Foilsithe in Neuro Oncol (2018)

First-in-human, phase I study of PF-06647263, an anti-EFNA4 calicheamicin antibody-drug conjugate, in patients with advanced solid tumors

le Garrido-Laguna, Ignacio, Krop, Ian, Burris, Howard A., Hamilton, Erika, Braiteh, Fadi, Weise, Amy M., Abu-Khalaf, Maysa, Werner, Theresa L., Pirie-Shepherd, Steven, Zopf, Christopher J., Lakshminarayanan, Mani, Holland, Jaymes S., Baffa, Raffaele, Hong, David S.
Foilsithe in Int J Cancer (2019)

A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease

le Vichinsky, Elliott, Onyekwere, Onyinye, Porter, John, Swerdlow, Paul, Eckman, James, Lane, Peter, Files, Beatrice, Hassell, Kathryn, Kelly, Patrick, Wilson, Felicia, Bernaudin, Françoise, Forni, Gian Luca, Okpala, Iheanyi, Ressayre-Djaffer, Catherine, Alberti, Daniele, Holland, Jaymes, Marks, Peter, Fung, Ellen, Fischer, Roland, Mueller, Brigitta U, Coates, Thomas
Foilsithe 2007

Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma

le Ellingson, Benjamin M, Aftab, Dana T, Schwab, Gisela M, Hessel, Colin, Harris, Robert J, Woodworth, Davis C, Leu, Kevin, Chakhoyan, Ararat, Raymond, Catalina, Drappatz, Jan, de Groot, John, Prados, Michael D, Reardon, David A, Schiff, David, Chamberlain, Marc, Mikkelsen, Tom, Desjardins, Annick, Holland, Jaymes, Ping, Jerry, Weitzman, Ron, Wen, Patrick Y, Cloughesy, Timothy F
Foilsithe in Neuro Oncol (2018)

Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

le Basch, Ethan M., Scholz, Mark, de Bono, Johann S., Vogelzang, Nicholas, de Souza, Paul, Marx, Gavin, Vaishampayan, Ulka, George, Saby, Schwarz, James K., Antonarakis, Emmanuel S., O’Sullivan, Joseph M., Kalebasty, Arash Rezazadeh, Chi, Kim N., Dreicer, Robert, Hutson, Thomas E., Dueck, Amylou C., Bennett, Antonia V., Dayan, Erica, Mangeshkar, Milan, Holland, Jaymes, Weitzman, Aaron L., Scher, Howard I.
Foilsithe in Eur Urol (2018)